| Literature DB >> 18357437 |
Hendrika Knoester1, Madelon B Bronner, Albert P Bos.
Abstract
OBJECTIVE: This study investigated the prevalence and nature of physical and neurocognitive sequelae in pediatric intensive care unit (PICU) survivors. DESIGN ANDEntities:
Mesh:
Year: 2008 PMID: 18357437 PMCID: PMC2480486 DOI: 10.1007/s00134-008-1061-4
Source DB: PubMed Journal: Intensive Care Med ISSN: 0342-4642 Impact factor: 17.440
Patient characteristics of PICU admission in participants and nonparticipants
| Participants ( | Nonparticipants ( |
| |
|---|---|---|---|
| Age of child, median (years; range) | 1.4 (0.1–17.3) | 1.5 (0.2–15.9) | 0.423 |
| Length of stay in PICU, median (days; range) | 6.0 (1.0–336.0) * | 4.0 (1.0–20.0) | 0.006 |
| Length of artificial ventilation, median (days; range) | 5.0 (0.0–119.0) * | 3.0 (0.0–19.0) | 0.004 |
| Risk of mortalitya, median (%; range) | 4.2 (0.2–80.7) | 3.8 (0.2–26.6) | 0.293 |
| Female | 68 (37%) | 23 (36%) | 0.929 |
| Reason for PICU admission * | 0.001 | ||
| Respiratory insufficiency | 77 (41%) | 33 (52%) | |
| Circulatory insufficiency | 31 (17%) | 13 (21%) | |
| Trauma | 44 (24%) | 9 (13%) | |
| Neurological disorder | 22 (12%) | 8 (12%) | |
| Metabolic disorder | 6 (3%) | 2 (3%) | |
| Gastrointestinal disorder | 6 (3%) | 0 (0%) | |
| Treatment characteristics (yes) | |||
| Artificial ventilation | 151 (81%) | 55 (86%) | 0.389 |
| Circulatory support | 46 (25%) | 16 (25%) | 0.966 |
| Neuromuscular blocking agents | 37 (20%) | 18 (28%) | 0.170 |
| Corticosteroids | 69 (37%) | 21 (33%) | 0.757 |
| Central venous catheter | 67 (36%) | 18 (28%) | 0.250 |
* p < 0.05 participants vs. nonparticipants; a Paediatric Index of Mortality II
Diagnosis at PICU discharge in participants and nonparticipants
| Participants ( | Nonparticipants ( |
| |||
|---|---|---|---|---|---|
|
| % |
| % | ||
| Respiratory insufficiency | 0.001 | ||||
| Pneumonia | 41 | 22 | 19 | 30 | |
| Upper airway obstruction | 19 | 10 | 13 | 20 | |
| Asthma | 13 | 7 | 0 | – | |
| Other | 4 | 2 | 1 | 2 | |
| Circulatory insufficiency | 0.001 | ||||
| Congenital heart disease | 14 | 8 | 0 | – | |
| Other cardiac disease | 4 | 2 | 1 | 2 | |
| Meningococcal disease | 11 | 6 | 8 | 12 | |
| Toxic shock syndrome | 0 | – | 4 | 6 | |
| Other septic shock | 2 | 1 | 0 | – | |
| Trauma | 0.001 | ||||
| Head trauma | 35 | 19 | 7 | 11 | |
| Other trauma | 9 | 5 | 1 | 2 | |
| Neurological disorder | 0.001 | ||||
| Status epilepticus | 15 | 8 | 5 | 8 | |
| Meningitis | 3 | 2 | 3 | 5 | |
| Other | 4 | 2 | 0 | – | |
| Metabolic disorder | 6 | 3 | 2 | 3 | – |
| Gastrointestinal disorder | 6 | 3 | 0 | – | – |
* p < 0.05 participants vs. nonparticipants
Physical sequelae 3 months after discharge in 186 participants (more than one problem per child possible): pre-PICU morbidity is a previously unknown underlying illness that was diagnosed during PICU admission; acquired morbidity is morbidity in a child that was healthy before PICU admission
| Pre-PICU morbidity ( | Acquired morbidity ( | |||
|---|---|---|---|---|
|
| % |
| % | |
| Respiratory problems | 21 | 11 | 23 | 12 |
| Circulatory problems | 14 | 8 | 0 | – |
| Neurological problems | 6 | 3 | 48 | 26 |
| Metabolic disorder | 6 | 3 | ||
| Miscellaneous problems | 8 | 4 | 14 | 8 |
| Tracheotomy | – | – | 3 | 2 |
| Scars | – | – | 17 | 9 |
| Hoarseness | – | – | 5 | 3 |
| Postthrombotic syndrome | – | – | 7 | 4 |
Fig. 1Pediatric Cerebral Performance Category in 186 evaluated children 24 h before PICU admission, at PICU discharge, and 3 months after PICI discharge. Columns from left to right: black, normal; light gray, mild disability; dark gray, moderate disability; white, severe disabililty; medium gray, coma/vegatative state
Fig. 2Pediatric Overall Performance Category in 186 evaluated children. POPC scores 24 h before PICU admission, at PICU discharge and 3 months after PICI discharge. Columns from left to right: black, normal; light gray, mild disability; dark gray, moderate disability; white, severe disabililty; medium gray, coma/vegatative state